Nicholas Thatcher

Phase III Trial Comparing Supportive Care Alone With Supportive Care With Oral Topotecan in Patients With Relapsed Small-Cell Lung Cancer

Mary O’Brien, Tudor–Eliade Ciuleanu, H. Tsekov et al. · Journal of Clinical Oncology · 2006 · 639 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer

MH Bronchud, J.H. Scarffe, Nicholas Thatcher et al. · British Journal of Cancer · 1987 · 597 citations · Full text

Medicine, Hematology, Oncology +15

Temozolomide for the Treatment of Brain Metastases Associated With Metastatic Melanoma: A Phase II Study

Sanjiv S. Agarwala, John M. Kirkwood, Martin Gore et al. · Journal of Clinical Oncology · 2004 · 359 citations

Medicine, Oncology, Pharmacotherapy +17

Improving Survival Without Reducing Quality of Life in Small-Cell Lung Cancer Patients by Increasing the Dose-Intensity of Chemotherapy With Granulocyte Colony-Stimulating Factor Support: Results of a British Medical Research Council Multicenter Randomized Trial

Nicholas Thatcher, D.J. Girling, Penelope Hopwood et al. · Journal of Clinical Oncology · 2000 · 226 citations

Pharmacy, Oncology, Pharmacology +17

Aflibercept and Docetaxel Versus Docetaxel Alone After Platinum Failure in Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer: A Randomized, Controlled Phase III Trial

Rodryg Ramlau, Tudor–Eliade Ciuleanu, Silvia Novello et al. · Journal of Clinical Oncology · 2012 · 186 citations

Medicine, Oncology, Pharmacology +15